Phase I trial of insulin-coated gold nanoparticles administered in a transbuccal film to healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 30 Nov 2017
At a glance
- Drugs Insulin (Primary)
- Indications Diabetes mellitus
- Focus Adverse reactions; Pharmacokinetics
- 30 Nov 2017 According to a Aquestive Therapeutics media release, MonoSol Rx changed its name to Aquestive Therapeutics
- 03 May 2012 Top-line results will be presented at the European Summit for Clinical Nanomedicine (CLINAM) in 2012 as reported by Midatech and Monosol Rx.
- 01 Dec 2011 Status changed from not yet recruiting to recruiting.